Evidence map›Paper›PMID 39523243›Full record

ReviewBiological trace element research2025

Biosynthesis and Properties of Bismuth Nanoparticles: A Review.

Amin Sadeghi Dousari, Mojtaba Shakibaie, Mahbobeh Adeli-Sardou, Hamid Forootanfar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amin Sadeghi DousariMedical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Mojtaba ShakibaieDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Mahbobeh Adeli-SardouDepartment of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran.
Hamid ForootanfarDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. forootanfar@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, nanotechnology is becoming increasingly important among researchers around the world by helping them diagnose and treat various diseases that can threaten human life. Bismuth nanoparticles are among the numerous metal nanoparticles widely used due to their potential therapeutic applications. Variety of studies displayed the high potentials of bismuth nanoparticles in extraordinary antibacterial, antibiofilm, anticancer, and antioxidant effects, and it seems that these potentials can be used to address the challenges in the treatment of many diseases. They are among the metal nanoparticles biosynthesized by the green synthesis method in many studies. The use of green synthesis of nanoparticles has attracted the interest of many investigators because of its environmental friendliness, non-toxicity, and high stability. Microorganisms like bacteria, fungi, yeasts, actinomycetes, viruses, marine algae, and plants have been found to have the inherent potential to create metal nanoparticles intracellularly or extracellularly and are recognized as viable biofactories for the green synthesis of nanoparticles. The goal of this review article was to assess synthesized bismuth nanoparticles based on their green synthesis methods; properties in terms of shape, size, synthesis origin, and structure; and biological applications, including their antibacterial, antibiofilm, antioxidant, and cytotoxic uses.

Indexed as

Anti-Bacterial AgentsBismuthMetal NanoparticlesAnimalsAntineoplastic AgentsAntioxidantsGreen Chemistry TechnologyHumansAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsBismuthBiomedical applicationBiosynthesisBismuth nanoparticles

Identifiers

PMID39523243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.